https://www.indivior.com/our-science 2026-03-24 weekly 0.8 https://www.indivior.com/our-products 2026-01-07 weekly 0.8 https://www.indivior.com/our-impact 2026-01-08 weekly 0.8 https://www.indivior.com/investors 2026-01-08 weekly 0.8 https://www.indivior.com/our-science/our-scientific-leadership 2026-03-27 weekly 0.8 https://www.indivior.com/our-impact/ethical-business-practices 2026-03-12 weekly 0.8 https://www.indivior.com/our-impact/patient-safety-and-product-quality 2026-02-24 weekly 0.8 https://www.indivior.com/our-impact/organizations-we-work-with 2026-03-31 weekly 0.8 https://www.indivior.com/site-services/privacy-notice 2025-12-20 weekly 0.8 https://www.indivior.com/site-services/cookies 2026-03-12 weekly 0.8 https://www.indivior.com/site-services/accessibility 2025-12-22 weekly 0.8 https://www.indivior.com/international/australia 2026-04-02 weekly 0.8 https://www.indivior.com/international/french-canada 2026-04-02 weekly 0.8 https://www.indivior.com/international/germany 2026-04-02 weekly 0.8 https://www.indivior.com/international/finland 2026-04-02 weekly 0.8 https://www.indivior.com/international/uk 2026-01-26 weekly 0.8 https://www.indivior.com/latest 2026-04-02 weekly 0.8 https://www.indivior.com/ 2026-04-02 weekly 0.8 https://www.indivior.com/international/denmark 2026-04-02 weekly 0.8 https://www.indivior.com/international/sweden 2026-01-21 weekly 0.8 https://www.indivior.com/international/canada-en 2026-04-02 weekly 0.8 https://www.indivior.com/international/france 2026-04-02 weekly 0.8 https://www.indivior.com/our-company 2026-04-02 weekly 0.8 https://www.indivior.com/our-company/our-focus 2026-01-08 weekly 0.8 https://www.indivior.com/our-company/our-culture 2026-01-13 weekly 0.8 https://www.indivior.com/our-company/our-leadership 2026-02-05 weekly 0.8 https://www.indivior.com/international/israel 2026-04-02 weekly 0.8 https://www.indivior.com/international/italy 2026-04-02 weekly 0.8 https://www.indivior.com/international/norway 2026-01-21 weekly 0.8 https://www.indivior.com/our-company/our-culture/richmond 2026-04-02 weekly 0.8 https://www.indivior.com/latest/category/financial-news 2026-04-02 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-extends-leadership-position-in-substance-use-disorder-treatment 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/board-appointments-and-succession-plan-announced 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/department-of-health-and-human-services-announces-new-guidance 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-provides-preliminary-fy-2020-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-announces-fy-2020-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-reaches-settlement-with-reckitt-benckiser 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-fy-2020-financial-results-presentation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-q3-2018-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-provides-updates-on-key-business-drivers-and-expectations 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-announces-h1-and-q2-financial-results-2021 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-upcoming-investor-events 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-prepays-debt 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/holdings-in-company-08-21-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/holdings-in-company-08-10-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-preliminary-injunction-on-generic-sublingual-film-upheld 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/holdings-in-company-08-06-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-h1-2018-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-sees-fy-2018-net-revenue-and-adjusted-net-income-below-previous-expectations 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-responds-to-generic-suboxone-approves-and-dr-reddys-launch-at-risk 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-prepays-150-million-of-outstanding-debt 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/third-quarter-results-notification-and-call-information 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-recognizes-drug-and-alcohol-facts-week-2021 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/study-examining-impact-of-covid-19-pandemic-on-opioid-use-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/result-of-agm 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-unable-to-attend-investor-conference 2025-12-29 weekly 0.8 https://www.indivior.com/careers 2026-04-02 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-new-drug-submission-to-health-canada-for-sublocade 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-to-announce-first-quarter-2018-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-applauds-biden-administrations-new-buprenorphine-practice-guidelines 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-welcomes-white-house-announcement-prioritizing-expanded-access-to-evidence-based-treatment 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/support-for-patients-and-communities-act-of-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/morgan-stanley-annual-global-healthcare-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-q1-2018-results-on-track-fy-2018-guidance-reconfirmed-encouraging-sublocade-launch 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-regulatory-submission-to-australias-therapeutic-goods-administration 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-enters-into-an-exclusive-global-license-agreement-for-c4x-discoverys-orexin-antagonist-program 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-to-announce-and-present-half-year-2018-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/fda-approves-perseris-for-extended-release-injectable-suspension 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-files-complaints-asserting-new-suboxone-film-patent-against-anda-filers-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-responds-to-court-ruling-in-anda-litigation-and-announces-intention-to-appeal 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-2019-third-quarter-and-nine-months-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/new-analysis-from-one-year-study-of-monthly-buprenorphine 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-and-addex-enter-strategic-collaboration-to-accelerate-development-of-gabab-pams-for-addiction-disorder-treatments 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-provides-update-on-tax-position 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/annual-report-and-accounts-2017-and-agm-2018 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-launches-national-campaign 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-granted-temporary-restraining-order 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indiviorplc-directors-change-of-responsiblities 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-receives-subopena-from-california-department-of-insurance 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-enters-into-settlement-with-par-pharmaceutical-in-patent-infringement-case 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-ruling-by-court-of-appeals 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-to-announce-full-year-2017-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-validation-of-marketing-authorization-application 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-statement-regarding-reckitt-benckiser-settlement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-raises-fy-2019-net-revenue-and-net-income-guidance 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-to-participate-in-jeffries-2019-healthcare-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-files-complaints-asserting-new-suboxone-film-patent-against-and-a-filers 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-plc-q1-2019-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-directorate-changes 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/sublocade-is-now-available-as-first-and-only-monthly-injectable-buprenorphine-in-the-us 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indiviors-recover-study-findings 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/new-data-from-recover-study-reports-abstinence 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-q3-2021-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-plc-full-year-2017-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/the-lancet-publishes-phase-3-results-for-sublocade 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/patient-reported-outcomes-data-on-sublocade 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/company-believes-us-justice-department-is-fundamentally-wrong 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-statement-regarding-state-attorney-generals-recent-announcements 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-is-granted-temporary-restraining-order-on-generic-sublingual-film 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/announcement-of-national-institutes-of-health-grant-award 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-launch-of-perseris-for-treatment-of-schizophrenia-in-adults 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/journal-of-addiction-medicine-publishes-patient-centered-outcomes 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-new-study-data-in-patients-with-moderate-to-severe-opioid-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-announces-repricing-and-maturity-extension 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/fda-approves-sublocade-the-first-and-only-once-monthly-injectable-buprenorphine-forumulation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/jp-morgan-healthcare-conference-presentation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-to-announce-fy-2018-results-feb-14 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/q3-ytd-2017-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/court-of-appeals-for-federal-circuit 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/fda-advisory-committees-recommend-approval-of-indiviors-rbp-6000-for-the-treatment-of-opioid-use-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-h1-2019-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/fda-posts-advisory-committee-meeting-notice-for-rbp-6000-nda 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-submits-new-drug-application-to-us-fda-for-rbp-7000-risperidone-monthly-depot 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-responds-to-court-rulings-in-anda-litigation-and-announces-intention-to-appeal 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-announces-completion-of-redomiciliation-to-the-united-states 2026-01-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-announces-launch-of-suboxone 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-announces-nda-acceptance-of-rbp-7000-risperidone-monthly-depot 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/court-of-appeals-for-federal-circuit-denies-motion-for-rehearsing 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indiviors-nalscue-receives-marketing-authorization-from-french-regulatory-agency-ansm 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-enters-into-settlement-with-mylan-pharmaceuticals 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-enters-into-exclusive-license-agreement-with-hls-therapeutics 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-submits-new-drug-application-to-us-fda-for-rbp-6000-buprenorphine-monthly-depot 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-asserts-new-patent-against-anda-filers 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/reminder-rbp-6000-investor-event-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-chief-medical-officer-provides-testimony-before-the-presidential-commission 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/annual-report-and-accounts-2016-and-annual-general-meeting-2017 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/resignation-of-cary-clairborne-as-chief-financial-officer 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/2017-annual-general-meeting 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-to-announce-half-year-2017-results-on-july-27th 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/webcast-event-q1-2017-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-enters-into-agreement-with-alvogen 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-rbp-7000-top-line-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-raises-fy-2021-guidance 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-rbp-6000-nda-acceptance-with-priority-review-designation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-and-virginia-commonwealth-university-school-of-pharmacy-enter-academic-partnership 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-plc-appointment-of-non-executive-director 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/ceo-of-indivior-presented-at-jp-morgan-health-care-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-provides-preliminary-q3-2024-results-updates-fy-2024-guidance-group-continues-to-expect-sublocade-peak-net-revenue-of-1-5-billion 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-attends-the-ondcp-2024-oorm-manufacturers-meeting 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/q1-2017-indivior-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/web-cast-event-shaun-thaxter-presented-at-jefferies-global-health-care-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-opens-30-million-research-and-development-center-to-advance-treatment-innovation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/rbp-6000-data-presented-in-late-breaking-research-oral-session-annual-scientific-meeting 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/chief-financial-officer-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-plc-fy-2018-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-the-publication-of-new-data-on-the-comparative-effectiveness-of-intranasal-nalmefene-and-in-naloxone-in-a-translational-model 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-dosing-of-first-subject-with-indv-2000-in-a-phase-2-study-assessing-the-safety-and-efficacy-of-indv-2000-in-individuals-with-opioid-use-disorder 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-q4-fy-2023-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/rbp-6000-investor-event-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/rapid-initiation-with-once-monthly-sublocade-superior-to-standard-initiation-csam-2024 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-h1-2017-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/rbp-6000-phase-3-pk-pd-ro-and-heor-subanalyses 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-bardas-first-order-of-opvee-to-combat-opioids-and-aid-national-preparedness 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-to-host-analyst-teach-in-event-in-new-york-city 2026-01-13 weekly 0.8 https://www.indivior.com/latest/category/news/2019/indivior-to-divest-interest-in-china 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/court-provides-final-approval-of-settlement-with-direct-purchaser-class-in-the-multidistrict-antitrust-litigation 2026-01-13 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-responds-to-publication-of-a-letter-by-oaktree-capital-management 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-q2-2024-financial-results 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-provides-update-on-aelis-farmas-clinical-phase 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-provides-business-update-conference-call-at-8am-us-edt 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-announces-q1-2023-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-20announces-20q3-202024-20financial-20results 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-highlight-growing-body-of-data-on-sublocade 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indivior-plc-fy-2016-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-reaches-agreement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-reaches-agreement-with-end-payor-class-to-resolve-their-antitrust-multi-district-litigation-claims 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-a-new--100-million-share-repurchase-program-new-program-will-be-executed-over-an-accelerated-time-frame 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_announces_h1_and_q2_2023_financial_results_2023 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-q1-2024-financial-results 2026-01-13 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-announces-q3-2023-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_to_participate_in_bank_of_america_global_healthcare_conference_2023 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-prevails-in-striking-representative-claims-from-uk-shareholder-action 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indiviors-sublocade-rapid-induction-alternative-injection-site-prior-approval-supplement 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-enters-an-exclusive-licensing-agreement-with-alar-pharmaceuticals 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/trading-update-release 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-fy2021-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-to-participate-in-upcoming-investor-conferences 2026-02-24 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-bardas-first-order-of-opvee-c2-ae-to-combat-opioids-and-aid-in-national-preparedness 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-ncchc-press-release-2021 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-asam-2022-press-release 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indiviorplc-opvee-approval 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/additional-us-listing 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-fy-2021-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_statement_on_the_availability_of_opvee_nalmefene_nasal_spray 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-announces-health-canada-approval-of-sublocade 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-provides-update-on-aelis-farma-s-clinical-phase-2b-study-results-with-aef0117-in-participants-with-cannabis-use-disorder 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-publication-demonstrating-that-opvee-nalmefene-nasal-spray-rapidly-reverses-effects-of-opioid-induced-respiratory-depression-in-head-to-head-study-against-intranasal-naloxone 2026-01-06 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-to-announce-q2-h1-2021-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/recover-lt-press-release 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2017/indiviors-shaun-thaxter-to-present-at-the-jefferies-global-healthcare-conference-on-june-6th 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-statement-on-court-decision 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-to-announce-q1-2022-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/aelis-phase-2b-pr 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/for-mental-health-awareness-month-indivior-offers-hope-for-opioid-use-disorder-recovery 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-jefferies-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/board-appointment-barbara-ryan 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-statement-on-the-opiant 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_to_commence_trading_on_nasdaq 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-ny-legislation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-h1-q2-2022-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/biden-ndcs 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2026/new-cost-impact-model-highlights-potential-for-monthly-injectable-buprenorphine-to-reduce-staffing-burdens-in-correctional-facilities 2026-03-31 weekly 0.8 https://www.indivior.com/latest/category/news/2026/new-study-shows-adherence-to-monthly-injectable-buprenorphine-linked-to-lower-healthcare-utilization-and-costs-in-opioid-use-disorder 2026-03-11 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-dea-fentanyl-statement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-cmd-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-to-announce-q2h12022-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-q3-2022-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-sept22-conferences 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-announces-fy-2022-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-ncchc-press-release-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-2022-gm-approval 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_cpdd_2023 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/matact 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-cpdd-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-announces-nina-delorenzo 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2024/indivior-announces-a-new-100-million-share-repurchase-program 2026-01-09 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-dadr-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-applauds-united-states-surgeon-general-report 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/research-indicates-sustained-high-plasma-concentrations-of-buprenorphine 2026-01-13 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-to-announce-q4-fy-2022-results-and-host-webcast 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/statement-regarding-civil-complaint-filed-by-state-attorneys-general 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-settles-patent-dispute-with-teva-subsidiary-actavis 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-applauds-congressional-passage-of-bipartisan-comprehensive-addiction-and-recovery-act 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/rbp-6000-phase-3-top-line-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-notified-of-civil-complaint-filed-by-state-attorneys-general 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-annual-general-meeting 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-receives-fda-fast-track-designation-for-rbp-6000-buprenorphine-monthly-depot-for-treatment-of-opioid-use-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/h1-2016-indivior-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-half-year-2016-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-plc-research-and-development-day-in-new-york 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-plc-q1-financial-results-ahead-of-plan-full-year-guidance-confirmed 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/shaun-thaxter-presented-jeffries-health-care-conference-in-new-york 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/annual-report-and-accounts-2015-and-agm-2016 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-plc-directorate-change-2016 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/shaun-thaxter-ceo-of-indivior-plc-presented-at-the-jp-morgan-health-care-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/appointment-of-nonexecutive-chair 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/appointment-of-chief-financial-officer 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-reaches-agreement-with-direct-purchasers-to-resolve-antitrust-multi-district-litigation-provides-preliminary-q3-and-ytd-2023-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-mhaw-press-release 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-statement-ndcs 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-announces-2020-nine-months-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-plc-board-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-underscores-commitment-to-putting-patients-first-during-recovery-month 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-calls-for-widespread-commitment-to-tackling-stigma-in-patients-with-opiod-use-disorder 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/notice-of-annual-general-meeting 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/us-court-sentencing-of-former-ceo 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-q3-2022-announcement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-circular-general-meeting-notice-sept-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/us-government-agreement-with-former-ceo 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-r-and-d-day 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/q1-2020-indivior-financial-results-press-release 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-takes-strategic-alignment-actions 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/claim-filed-by-reckitt-benckiser-group-plc 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-opnt-111422 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-announces-patent-trial-and-appeal-board-ruling-in-dr-reddys-laboratories 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/shaun-thaxter-presented-at-the-deutsche-bank-annual-health-care-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/us-court-approval-of-agreement-with-justice-department 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-announces-intention-to-list-adrs-in-us 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/directorate-change 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/sublocate-long-term-safety-data-published-in-journal-of-clinical-psycho-pharmacology 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-receives-approval-for-subutex-prolonged-release-solution-for-injection 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/statement-on-the-coronavirus-and-global-supply-of-medicines 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/result-of-phase-1-trial-of-rbp-6300-buprenorphine-hemiadipate 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/one-year-outcomes-of-real-world-recover-study-published-in-journal-of-addiction-medicine 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/white-house-office-national-drug-control-policy 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/new-data-from-recover-study-reveal-two-outcomes 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-to-participate-in-the-piper-sandler-37th-annual-healthcare-conference 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-concludes-legacy-us-department-of-justice-matter 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2020/annual-report-and-accounts-2019-and-agm-2020 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-withdraws-fy-2020-guidance-in-face-of-current-covid-19-uncertainty 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/an-open-letter-to-our-stakeholders-from-our-interim-board-chair-and-ceo-regarding-indivior-agreement 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/new-study-extended-release-buprenorphine-safely-delivers-rapid 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-to-announce-and-present-fy-2019-results-on-february-13th 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/new-real-world-evidence-at-nexus-2025 2026-02-04 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-inclusion-in-the-sp-smallcap-600-Index 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2020/motion-to-expedite-drls-appeal-of-indiviors-preliminary-injunction-granted-in-part 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-full-year-2015-financial-results-ahead-of-plan 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-reports-second-quarter-2025-financial-results-and-raises-fy-2025-financial-guidance 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-to-participate-in-the-upcoming-investor-events 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-completion-of-cancellation-of-secondary-listing-on-london-stock-exchange-primary-listing-on-nasdaq-to-be-maintained 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-announces-fy-2019-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/webcast-event-indivior-full-year-2015-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-to-participate-in-the-stifel-2025-healthcare-conference 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-inc-receives-a-paragraph-iv-notice-of-certification-letter 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-proposes-new-corporate-structure-to-achieve-us-domiciliation 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-q1-2025-financial-results 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-joseph-ciaffoni-appointed-chief-executive-officer 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2016/morgan-stanley-conference-new-york-presentation-2016 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/clinical-evidence-supports-rapid-sublocade-induction 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior_plc_form_20-f_registration_statement_for_additional_us_listing 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-to-announce-q1-2020-results-may-14 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-reports-third-quarter-2025-financial-results-and-raises-fy-2025-financial-guidance 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-appoints-vanessa-procter-as-executive-vice-president-of-corporate-affairs 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-statement-re-delayed-fda-approval-of-sublocade-label-changes 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-announces-first-half-and-second-quarter-2020-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-fy-and-q4-2024-financial-results 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2023/indivior-completes-acquisition-of-opiant-pharmaceuticals-inc 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-further-changes-to-board-of-directors 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-welcomes-court-ruling-on-anda-litigation 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-announces-q1-2021-financial-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-real-world-evidence-study-finds-medications-for-opioid-use-disorder-particularly-extended-release-buprenorphine-reduced-odds-of-emergency-department-visits-for-patients-with-opioid-use-disorder 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2016/indivior-plc-the-company-directorate-change 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indivior-jci-publication-2022 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-announces-agreement-to-resolve-criminal-charges-and-civil-complaints-related-to-suboxone-film 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-reports-third-quarter-2025-financial-results-and-host-webcast 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2016/nine-month-financial-results-litigation-provision-of-220m-booked 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2016/presentation-indivior-full-year-2015-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-presents-new-data-at-cpdd-demonstrating-that-high-buprenorphine-exposure-may-improve-treatment-outcomes-in-high-fentanyl-users 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-inclusion-in-the-u-s--russell-2000-and-3000-es 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2020/appointment-of-chief-executive-officer 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-to-participate-in-upcoming-investor-conferences 2025-12-29 weekly 0.8 https://www.indivior.com/our-company/our-culture/raleigh 2026-04-02 weekly 0.8 https://www.indivior.com/latest/category/financial-news/2026/indivior-to-report-q4-and-fy2025-and-host-webcast-on-feb-26th 2026-01-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/perseris-the-first-once-monthly-risperidone 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-fda-approval-of-label-changes-for-sublocade-injection 2026-01-07 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-provides-fy-2026-financial-guidance-and-business-update 2026-03-17 weekly 0.8 https://www.indivior.com/latest/category/news/2025/-20indivior-appoints-tony-kingsley-to-the-board-of-directors 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2020/indivior-statement-related-to-a-claim-filed-against-it 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2025/indivior-announces-patrick-barry-as-chief-commercial-officer 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-reports-fourth-quarter-and-full-year-2025-financial-results 2026-02-26 weekly 0.8 https://www.indivior.com/latest/category/news/2025/new-study-highlights-monthly-sublocade-as-a-potential-treatment-option-for-oud 2026-01-08 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-announces-proposed-convertible-senior-notes-offering 2026-03-11 weekly 0.8 https://www.indivior.com/latest/category/news/2021/albatros 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2022/indv-q1-2022-results 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2026/only-58-percent-of-us-correctional-facilities-offer-medications-for-opioid-use-disorder 2026-03-17 weekly 0.8 https://www.indivior.com/latest/category/news/2018/court-of-appeals-for-federal-circuit-declines-to-immediately-issue-mandate 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-nov21-investor-conferences 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2026/indivior-prices-upsized-450-million-convertible-senior-notes-offering 2026-03-13 weekly 0.8 https://www.indivior.com/latest/category/news/2018/court-of-appeals-for-the-federal-circuit-lifts-preliminary-injunction-on-generic-sublingual-film 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2018/indivior-publishes-design-and-patient-characteristics-for-real-world-study 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-presents-new-data-at-the-college-on-problems-of-drug-dependance 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-to-present-new-data-on-opioid-use-disorder-at-csam-smca-2021-scientific-conference 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2021/indivior-acop-pressrelease 2025-12-29 weekly 0.8 https://www.indivior.com/latest/category/news/2019/virginia-tech-and-indivior-announce-new-collaboration 2025-12-29 weekly 0.8